80 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Modulation of the Inhibitors of Apoptosis Proteins (IAPs) Activities for Cancer Treatment.
Therachem Research Medilab (India)
Targeting the Inhibition of Tryptophan 2,3-Dioxygenase (TDO-2) for Cancer Treatment.
Therachem Research Medilab (India)
Potential of Renal Outer Medullary Potassium (ROMK) Channel as Treatments for Hypertension and Heart Failure.
Therachem Research Medilab (India)
Great Therapeutic Potential of Peptidylarginine Deiminase 4 (PAD4) Inhibitors: Treatment of Rheumatoid Arthritis, Epigenetic Tools, Regulation of Pluripotency in Stem Cells, and More.
Therachem Research Medilab (India)
Potential Treatment of Cognitive Impairment in Schizophrenia by Phosphodiesterase 2 (PDE2) Inhibitors.
Therachem Research Medilab (India)
Protease-Activated Receptor 1 (PAR-1) Antagonists as Potential Treatment for Acute Coronary Syndrome.
Therachem Research Medilab (India)
Therapeutic Potential of Smurf-1 Inhibitors for the Treatment of Pulmonary Arterial Hypertension (PAH).
Therachem Research Medilab (India)
Therapeutic Potential for Modulation of Nrf2-Keap-1 Signaling Pathway as Treatment for Diabetes and Other Disorders.
Therachem Research Medilab (India)
Targeting the Follicle Stimulating Hormone Receptor (FSHR) To Treat Fertility Disorders.
Therachem Research Medilab (India)
Glutaminase GLS1 Inhibitors as Potential Cancer Treatment.
Therachem Research Medilab (India)
Potential Use of Inhibitors of Tankyrases and PARP-1 as Treatment for Cancer and Other Diseases.
Therachem Research Medilab (India)
MALT1 Inhibitors May Potentially Treat Lymphomas and Autoimmune Disorders.
Therachem Research Medilab (India)
Inhibition of Histone Demethylases Offers a Novel and Promising Approach for the Treatment of Cancer and Other Diseases.
Therachem Research Medilab (India)
Inhibitors of the Antiapoptotic Myeloid Cell Leukemia-1 (Mcl-1) May Provide Effective Treatment for Cancer.
Therachem Research Medilab (India)
RORc Modulators for the Treatment of Autoimmune Diseases.
Therachem Research Medilab (India)
Nav1.7 Inhibitors: Potential Effective Therapy for the Treatment of Chronic Pain.
Therachem Research Medilab (India)
Kynurenine Monooxygenase (KMO) Inhibitors for the Treatment of Acute Pancreatitis and Neurodegenerative Disorders.
Therachem Research Medilab (India)
Prokineticin Receptor Modulators May Potentially Treat Psychiatric and Neurological Disorders.
Therachem Research Medilab (India)
Fatty Acid Synthase (FASN) Inhibitors as Potential Treatment for Cancer, Obesity, and Liver Related Disorders.
Therachem Research Medilab (India)
Inhibitors of the Epidermal Growth Factor Receptor (EGFR) May Provide Effective Treatment for Lung Adenocarcinoma.
Therachem Research Medilab (India)
Indoleamine 2,3-dioxygenase inhibitors: potential treatment for cancer, sepsis, and more.
Therachem Research Medilab (India)
Prostaglandin EP3 Receptor Antagonists May Provide Novel Treatment for Diabetes.
Therachem Research Medilab (India)
Inhibitors of the PD-1/PD-L1 Pathway Can Mobilize the Immune System: An Innovative Potential Therapy for Cancer and Chronic Infections.
Therachem Research Medilab (India)
Inhibitors of the PAR-2 Signaling Pathway May Treat Pain and Inflammation.
Therachem Research Medilab (India)
Rho kinase inhibitors: potentially versatile therapy for the treatment of cardiovascular diseases and more.
Therachem Research Medilab (India)
Treating pain with somatostatin receptor subtype 4 agonists.
Therachem Research Medilab (India)
Allosteric modulators: an emerging concept in drug discovery.
Therachem Research Medilab (India)
The role of enhancer of zeste homologue 2 inhibitors in controlling epigenetics and their potential for cancer treatment.
Therachem Research Medilab (India)
ROR¿t Modulators Are Potentially Useful for the Treatment of the Immune-Mediated Inflammatory Diseases.
Therachem Research Medilab (India)
MoGAT-2 Inhibitors May Provide Effective Treatment for Hypertriglyceridemia.
Therachem Research Medilab (India)
Pim kinase inhibitors for the treatment of cancer and possibly more.
Therachem Research Medilab (India)
P21-Activated Kinase 4 (PAK4) Inhibitors as Potential Cancer Therapy.
Therachem Research Medilab (India)
RET Kinase Inhibitors May Treat Cancer and Gastrointestinal Disorders.
Therachem Research Medilab (India)
Dual leucine zipper kinase inhibitors: potential treatments for neurodegenerative diseases.
Therachem Research Medilab (India)
Inhibition of O-GlcNAcase (OGA): A Potential Therapeutic Target to Treat Alzheimer's Disease.
Therachem Research Medilab (India)
GnRH antagonists: the promise of treating sex-hormone-related diseases.
Therachem Research Medilab (India)
Liver x receptor agonists for the treatment of coronary heart disease and other disorders.
Therachem Research Medilab (India)
Neutrophil elastase inhibitors as potential anti-inflammatory therapies.
Therachem Research Medilab (India)
Treatment of Immunological or Inflammatory Disorders with ITK Kinase Inhibitors.
Therachem Research Medilab (India)
Inhibitors of Factor XIa and Plasma Kallikrein May Treat Thromboembolic Disorders and Many Diabetes Complications.
Therachem Research Medilab (India)
Selective 5-HT Receptor Modulators May Deliver Focused Targeting with Fewer Adverse Effects.
Therachem Research Medilab (India)
β-Secretase Inhibitors for the Treatment of Alzheimer's Disease and Down's Syndrome.
Therachem Research Medilab (India)
Selective EP4 Antagonist May Be Useful in Treating Arthritis and Arthritic Pain.
Therachem Research Medilab (India)
Inhibitors of factor d may provide a treatment for age-related macular degeneration.
Therachem Research Medilab (India)
Inhibitors of Tropomyosin-Receptor Kinases (Trk's): Potential Pain Therapy and More.
Therachem Research Medilab (India)
Endothelial lipase inhibitors for the treatment of atherosclerosis and cardiovascular disorders.
Therachem Research Medilab (India)
Fighting Obesity and Metabolic Disorders with MGAT-2 Inhibitors.
Therachem Research Medilab (India)
Inhibitors of PI3Kβ as Potential Treatment for Cancer.
Therachem Research Medilab (India)
Targeting CCR2 Receptor To Treat Inflammation Diseases and Disorders.
Therachem Research Medilab (India)
PDE10 Inhibitors as Potential Treatment for Schizophrenia.
Therachem Research Medilab (India)
TRPV4 Antagonists: Potential Treatment for Congestive Heart Failure, Bladder Dysfunctions, and Pain.
Therachem Research Medilab (India)
Aldosterone synthase inhibitors: targeting chronic kidney disease and diabetic nephropathy.
Therachem Research Medilab (India)
Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders: Patent Highlight.
Therachem Research Medilab (India)
Treatment of Obesity and Related Disorders with Acetyl-CoA Carboxylase Inhibitors.
Therachem Research Medilab (India)
Antagonists of Orexin Receptors as Potential Treatment of Sleep Disorders, Obesity, Eating Disorders, and Other Neurological and Psychiatric Disorders.
Therachem Research Medilab (India)
Treatment of Metabolic Disorders with CB-1 Receptor Inverse Agonists.
Therachem Research Medilab (India)
Targeting the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein for the Treatment of Cystic Fibrosis.
Therachem Research Medilab (India)
Potential Treatment for Neuropsychiatry Disorders with TRPC5 Modulators.
Therachem Research Medilab (India)
Tankyrase inhibitors: potential treatment of hyperproliferative diseases.
Therachem Research Medilab (India)
Inhibition of CK2: An Attractive Therapeutic Target for Cancer Treatment.
Therachem Research Medilab (India)
Sphingosine-1-phosphate (S1P) Receptor Modulators Provide Potential for Diverse Treatments.
Therachem Research Medilab (India)
Histone Deacetylase 4 (HDAC4) Inhibitors: A Promising Treatment for Huntington's Disease.
Therachem Research Medilab (India)
FPRL-1 Receptor Modulators May Provide Treatment for Inflammation.
Therachem Research Medilab (India)
Potassium channel modulators as possible treatment for pain: patent highlight.
Therachem Research Medilab (India)
Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Potential Treatment for Different Types of Cancers.
Therachem Research Medilab (India)
Selective Inhibitors of Phosphodiesterase 4B (PDE-4B) May Provide a Better Treatment for CNS, Metabolic, Autoimmune, and Inflammatory Diseases.
Therachem Research Medilab (India)
Selective Estrogen Receptor Degraders (SERDs): A Promising Treatment to Overcome Resistance to Endocrine Therapy in ERα-Positive Breast Cancer.
Therachem Research Medilab (India)
Inhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune Diseases.
Therachem Research Medilab (India)
Potential of PI3Kβ Inhibitors in the Treatment of Cancer and Other Diseases.
Therachem Research Medilab (India)
Plasma Kallikrein Inhibitors for the Treatment of Retinal Vascular Permeability Associated with Diabetic Retinopathy and Diabetic Macular Edema.
Therachem Research Medilab (India)
Janus-Associated Kinase 1 (JAK1) Inhibitors as Potential Treatment for Immune Disorders.
Therachem Research Medilab (India)